FEDERAL COURT OF AUSTRALIA
Sanofi-Aventis Deutschland GmbH v Alphapharm Pty Ltd [2018] FCA 1426
File number(s): NSD 1502 of 2018 Judge(s): BURLEY J Date of judgment: 11 September 2018 Catchwords: PRACTICE AND PROCEDURE – patents – application to set aside a notice to produce seeking documents recording or evidencing an assessment of the invalidity and proposed amendments to the Australian patent in suit and overseas equivalents – where the documents were sought in support of the respondent’s defence to an interlocutory injunction application rather than the patentee’s interlocutory application to amend the patent in suit pursuant to s 105 of the Patents Act 1990 (Cth) – notice to produce set aside Legislation: Competition and Consumer Act 2010 (Cth), Schedule 2, s 18
Patents Act 1990 (Cth), s 105
Cases cited: Apotex v Les Laboratoires Servier and anor (No 4) [2015] FCA 104; (2015) 111 IPR 160
Australian Broadcasting Corporation v O’Neill [2006] HCA 46; 227 CLR 57
Beecham Group Ltd v Bristol Laboratories Pty Ltd [1968] HCA 1; 118 CLR 618
Les Laboratoires Servier and Another v Apotex Pty Ltd [2016] FCAFC 27 ; (2016) 247 FCR 61
Neurim Pharmaceuticals (1991) Ltd v Generic Partners Pty Ltd [2018] FCA 1082
Samsung Electronics Co Ltd v Apple Inc [2011] FCAFC 146; 217 FCR 238
Seven Network Ltd v News Ltd (No 11) [2006] FCA 174
Date of hearing: 11 September 2018 Registry: New South Wales Division: General Division National Practice Area: Intellectual Property Sub-area: Patents and associated Statutes Category: Catchwords Number of paragraphs: 16 Counsel for the Applicants: Mr C Dimitriadis SC and Mr A Lang Solicitors for the Applicants: Jones Day Counsel for the Respondent: Mr B Caine QC and Mr J Cooke Solicitors for the Respondent: MinterEllison ORDERS
NSD 1502 of 2018 BETWEEN: SANOFI-AVENTIS DEUTSCHLAND GMBH
First Applicant
SANOFI-AVENTIS PTY LTD
Second Applicant
AND: ALPHAPHARM PTY LTD
Respondent
JUDGE:
BURLEY J
DATE OF ORDER:
11 SEPTEMBER 2018
THE COURT ORDERS THAT:
1.On or before 3 September 2018, the Applicants provide to the Commissioner of Patents copies of:
(a)an advertisement stating the matters identified in r 34.41(1)(a) to (d) of the Federal Court Rules 2011 (Cth) with respect to the Amendment Application; and
(b)these orders,
and invite the Commissioner of Patents to confirm if the Commissioner wishes to be heard on the Amendment Application.
2.The Applicants are to request the Commissioner of Patents to publish the advertisement referred to in Order 1(a) in the next edition of the Official Journal.
3.On or before 7 September 2018, the Applicants file and serve:
(a)an affidavit in support of the Amendment Application; and
(b)a copy of the communications referred to in orders 1 and 2.
Application for interlocutory injunction
In respect of the Applicants’ interlocutory application dated 20 August 2018 for interlocutory injunctive relief (Interlocutory Injunction Application):
4.The Applicants:
(a)subject to order 4(b) file and serve any further affidavit evidence in support of the Interlocutory Injunction Application on or before 31 August 2018; and
(b)in respect…
Keep reading for free
Create a free CaseChat account to read Sanofi-Aventis Deutschland GmbH v Alphapharm Pty Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2018] FCA 1426
- Decision Date
CaseChat Overview and Summary
The legal issues before the court centred on the propriety of a notice to produce documents that Alphapharm had been ordered to provide. Specifically, the court had to determine whether the notice, which sought documents recording or evidencing an assessment of the invalidity of the patent and proposed amendments to the Australian patent and its overseas equivalents, was appropriately issued. The dispute arose because the documents were sought in support of Alphapharm's defence to an interlocutory injunction application, rather than in response to the patentee's application to amend the patent pursuant to section 105 of the Patents Act 1990 (Cth).
In deciding the matter, the court considered the context in which the notice to produce was issued. It was noted that the documents were relevant to Alphapharm's defence and not directly to the patentee's application to amend the patent. The court held that the notice was improperly issued and set it aside, emphasising the need for clarity in the procedural steps in patent litigation and the importance of ensuring that document requests are aligned with the specific application they support. The decision underscored the necessity of adhering to procedural fairness and the relevance of documents to the specific issues in contention.
As a result of the court's decision, the notice to produce was set aside, and no further orders were made regarding the production of the documents in question. The case highlights the importance of precision in procedural requests within patent litigation, ensuring that each step aligns with the specific application and defence strategies being pursued by the parties.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi